Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00628836
Other study ID # BT3
Secondary ID
Status Completed
Phase Phase 1
First received February 25, 2008
Last updated June 1, 2015
Start date June 2001
Est. completion date December 2008

Study information

Verified date June 2015
Source University of Southern California
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The study looks at treatments for reversing chronic shoulder subluxation after a stroke. It compares electrical stimulation with surface electrodes (stimulation through the skin) with intra-muscular stimulation (from inside the muscle)using an implanted micro-stimulator (BION). Subjects are put either in a surface stimulation or a BION® group. In the BION® group, two BION®s are implanted in the shoulder, the medial deltoid and supraspinatus muscles. Treatment consists of a baseline of 6 weeks, and 6 weeks of therapy, consisting of 2 sessions per day for 10 to 30 minutes each time. This is followed by 6 weeks without therapy. If testing shows that after 6 weeks of therapy there is no reversal of subluxation, more intense therapy is carried out for another 6 weeks. Treatment is similar in the surface electrode group, but surface electrodes deliver the stimulation instead of BION®s. A total of 30 subjects is expected to complete the study.


Description:

The BION™ is a novel implantable neuromuscular stimulator whose intended use in this study is to reanimate the shoulder muscles of stroke survivors with shoulder subluxation. Strokes are considered to be the most important cause of adult disability in North America, with 500,000 new cases per year in the U.S. (National Stroke Association) and 45,000 in Canada (Langton-Hewer, 1990; Shuaib & Hachinski, 1991). Three-quarters of these patients survive and half of the survivors have substantial muscle weakness after 6 months (Gresham et al., 1979) with little chance of spontaneous recovery (Anderson, 1990; Bonita & Beaglehole, 1988). The most commonly affected region in the early phases of recovery is the shoulder; 80% of hemiplegic stroke patients suffer from shoulder subluxation and associated chronic pain (Smith et al., 1980). The shoulder muscles that are normally active tonically are flaccidly paralyzed; the weight of the pendant arm gradually stretches and damages the atrophic muscles and ligaments, allowing the head of the humerus to descend out of the glenoid fossa. This results in chronic shoulder pain that is difficult to treat and tends to obstruct physical therapy directed toward regaining some use of the paretic arm. Our hypothesis is that electrical stimulation delivered by the BIONs should be fundamentally equivalent to muscle activation achieved voluntarily or by transcutaneous electrical nerve stimulation (TENS), but that the BIONs will prove to be a more clinically acceptable and effective approach. The BION system consists of the BION implants themselves, a controller that is operated by the study participant, and fitting hardware and software used by the clinician to implant, test, and program BION function.

In this study, the BION will be used to reanimate the shoulder muscles of stroke survivors experiencing shoulder subluxation. The objective of this study is to evaluate the safety and efficacy of intramuscular stimulation of BIONs to correct established, symptomatic shoulder subluxation in chronic stroke survivors. The results of intramuscular stimulation by BIONs will be compared with the results of treatment with conventional therapy: surface stimulation.

Degree of shoulder subluxation will be the primary outcome measure for the study. We have included other (secondary) outcome measures (i.e., muscle strength, range of motion, functional activity, spasticity/tone, subject satisfaction and pain) which may reveal secondary benefits of treatment with BIONs. The investigation is expected to last up to 21 weeks for each study participant. The study will be completed over a 5-year period.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date December 2008
Est. primary completion date December 2008
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:1.

1. Diagnosis of hemiplegic stroke at least 6 months prior to enrollment;

2. Paresis of the shoulder muscles;

3. Shoulder subluxation (i.e., a positive sulcus sign of 5 mm or more);

4. Age 18 years or older;

5. Stable use of pain medication for at least one month prior to enrollment;

6. Medically stable;

7. Able to travel to the testing center;

8. Mentally capable to understand and carry out the procedures and communicate concerns; and

9. Willing to participate and provide informed consent.

Exclusion Criteria:

1. Pregnant, nursing, or planning to become pregnant within the next four months;

2. Presence of electronic implants (e.g., cardiac pacemaker, cochlear implant, neurostimulator, etc.);

3. Presence of metallic implants in the immediate field of the magnetic coil:

4. Use of using electrical stimulation for treatment of their subluxed shoulder in the past month;

5. Inability to recruit muscles through surface electrical stimulation because of excessive adipose tissue;

6. Presence of other unrelated shoulder problems;

7. Severe hemineglect ( patient is unable to acknowledge or answer questions about the involved limb)

8. Cancer or other serious illness, including a disease other then stroke resulting in dysfunction of movement.

9. Subject is currently enrolled in another clinical trial or research study that involves therapy or intervention to the upper limb.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
BION stimulation
The study will have two phases, each with a six week duration. During phase 1, the BION group will be implanted with BIONs in the middle deltoid and supraspinatus muscles. The muscles will be stimulated electrically by way of the BION and an external controller for one to two hours per day at 5pps in an on-off duty cycle train. The SE group will begin surface stimulation similar to that of BE group. Subjects in either group whose initial therapy in phase 1 successfully reduces the amount of shoulder subluxation to 5mm or less will go off stimulation for six weeks, and be reassessed whether subluxation is redeveloping. If a subject in either group does not respond sufficiently to phase 1 therapy, the participant will move to phase 2 where the shoulder will be stimulated at up to 25 pps either with surface stimulation (SE group) or BION stimulation (BE group) for another six weeks. At the end of phase 2, participants will go off stimulation for six weeks and then be reevaluated.

Locations

Country Name City State
United States Rancho Los Angeles National Rehabilitation Center Downey California

Sponsors (1)

Lead Sponsor Collaborator
University of Southern California

Country where clinical trial is conducted

United States, 

References & Publications (1)

Loeb GE, Richmond FJ, Baker LL. The BION devices: injectable interfaces with peripheral nerves and muscles. Neurosurg Focus. 2006 May 15;20(5):E2. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Degree of shoulder subluxation by x-ray 6 weeks No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05635240 - Chronic Anterior Shoulder Instability in the Military
Recruiting NCT02913352 - Latarjet Versus Modified Eden-Hybinette for Anterior Shoulder Dislocation N/A
Completed NCT03154957 - Management of Acute Dislocation of Emergency in the University Hospital of Strasbourg Shoulder: Retrospective Evaluation of Practices and Proposal of a Clinical Path
Recruiting NCT02510625 - The Arthroscopic Treatment of Recurrent Anterior Shoulder Instability N/A
Completed NCT00707018 - Immobilization in External Rotation After First Time Anterior Shoulder Dislocation N/A
Recruiting NCT04887337 - Early arthroscoPic Stabilization veRsus rehabilitatiOn of the Shoulder in Adolescents With a trauMatic First-time Anterior Shoulder Dislocation ePisode N/A
Completed NCT04960137 - Shoulder Dislocations Treated With Button Plates and Non-absorbable Suture Anchor N/A
Recruiting NCT05388942 - Virtual Reality Hypnosis Versus Inhaled Nitrous Oxide in Anterior Shoulder Dislocation Reduction: an Open Multicenter Randomized Controlled Trial N/A
Completed NCT02725333 - Does Shoulder Stabilizations Stabilize Shoulders? N/A
Recruiting NCT05705479 - Shoulder Instability Trial Comparing Arthroscopic Stabilization Benefits Compared With Latarjet Procedure Evaluation - STABLE Definitive Trial N/A
Not yet recruiting NCT05048303 - Multicenter Clinical Cohort Study of Modified Flexible Fixation Latarjet Procedure for Recurrent Shoulder Dislocation N/A
Recruiting NCT03453710 - Remplissage Versus Latarjet Coracoid Transfer for Recurrent Shoulder Instability N/A
Recruiting NCT04952636 - A Prospective Comparative Study of Arthroscopic and Open Surgery in Cuistow Procedure N/A
Completed NCT00251264 - Arthroscopic Versus Open Stabilization for Traumatic Shoulder Instability N/A
Terminated NCT02426996 - The Latarjet-type Procedure Using the SEM Positioner: Using a Scan to Assess Consolidation N/A
Completed NCT04022629 - ASSET 2 Study: Long-Term Follow-up of a Randomised Control Trial Phase 2/Phase 3
Terminated NCT04820491 - Efficient Anterior Shoulder Ultrasound Reduction Multicenter Prospective Randomized Trial N/A
Recruiting NCT05443295 - Improvement of Fatigue in Unstable Shoulder Through a Therapeutic Exercise Program in Physiotherapy N/A
Completed NCT06459258 - Throwing Velocity and Patient Reported Outcomes in Elite Level Handball Players After Completion of Shoulder-Pacemaker Strength Training N/A
Completed NCT04479397 - Sling vs Nothing After Latarjet Procedure N/A

External Links